Q4 2019 NovaBay Pharmaceuticals Inc Earnings Call Transcript
Welcome to the NovaBay Pharmaceuticals 2018 (sic - "2019") fourth-quarter and full-year's earning conference call. (Operator Instructions) As a reminder, this conference is being recorded Thursday, March 26, 2020.
I would now like to turn the conference over to Jody Cain. Please go ahead.
This is Jody Cain with LHA. Thank you for participating in today's call. Joining me from NovaBay Pharmaceuticals are Justin Hall, President, and Chief Executive Officer; and Jason Raleigh, the company's Chief Financial Officer.
I'd like to remind listeners that comments made during this call by management will include forward-looking statements within the meaning of Federal Securities Laws. These forward-looking statements involve risks and uncertainties that could cause actual results to be materially different from any anticipated results.
For a list and description of those risks and uncertainties, please review NovaBay's filings with the Securities and Exchange Commission at sec.gov. Furthermore, the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |